Novel analytical method to evaluate the surface condition of polyethylene glycol-modified liposomes

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 397, Issue , 2012, Pages 73-79

  Yoshino, Keisuke ^a   Taguchi, Kyouko ^a   Mochizuki, Mayu ^a   Nozawa, Shigenori ^a   Kasukawa, Hiroaki ^a   Kono, Kenji ^b  

^a TERUMO CORPORATION   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Deviation of PEG lipid; Liposome preparation method; Liposomes; Long circulation; Polyethylene glycol (PEG)

Indexed keywords

COLUMN CHROMATOGRAPHY; DRUG DELIVERY; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; QUALITY CONTROL;

ANALYTICAL METHOD; ANION EXCHANGE COLUMNS; BLOOD STREAMS; CIRCULATION TIME; CLINICAL USE; DEVIATION OF PEG-LIPID; LIPOSOME MEMBRANES; MANUFACTURING PROCESS; PEGYLATED LIPOSOMES; SURFACE CONDITIONS;

LIPOSOMES;

LIPID; LIPOSOME; MACROGOL;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); EVALUATION; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 84858341506     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2012.01.035     Document Type: Article

References (30)

1. Nishioka Y., Yoshino H. Lymphatic targeting with nanoparticulate system. Adv. Drug Deliv. Rev. 2001, 1:55-64.
2. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
3. Fenske D.B., Cullis P.R. Liposomal nanomedicines. Expert Opin. Drug Deliv. 2008, 5:25-44.
4. Allen T.M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta 1989, 981:27-35.
5. Liu D., Mori A., Huang L. Role of liposomes size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim. Biophys. Acta 1992, 1104:95-101.
6. Devine D.V., Wong K., Serrano K., Chonn A., Cullis P.R. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1994, 1191:43-51.
7. Papisov M.I. Theoretical consideration of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions. Adv. Drug Deliv. Rev. 1998, 32.
8. Mayer L.D., Tai L.C., Ko D.S., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989, 49:5922-5930.
9. Harris J.N., Martin N.E., Mode M. Pegylation. Clin. Pharmacokinet. 2001, 40:539-551.
10. Blume G., Cevc G. Liposome for the sustained drug release in vivo. Biochim. Biophys. Acta 1990, 1029:91-97.
11. Woodle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1992, 1113:171-199.
12. Lasic D.D., Needlham D. The stealth liposome: a prototypical biomaterial. Chem. Rev. 1995, 95:2601-2628.
13. Bedu-Addo F.K., Huang L. Interaction of PEG-phospholipid conjugates with phospholipids: implications in liposomal drug delivery. Adv. Drug Deliv. Rev. 1995, 16:235-247.
14. Bedu-Addo F.K., Tang P., Xu Y., Huang L. Effects of polyethylene-glycol chain length and phospholipids acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipids: implications in liposomal drug delivery. Pharm. Res. 1996, 13:710-717.
15. Du H., Chandaroy P., Hui S.W. Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim. Biophys. Acta 1997, 1326:236-248.
16. Price M.E., Cornelius R.M., Brash J.L. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma. Biochim. Biophys. Acta 2001, 1512:191-205.
17. Auguste D.A., Prud'homme R.K., Ahl P.L., Meers P., Kohn J. Association of hydrophobically-modified poly(ethylene glycol) with fusogenic liposomes. Biochim. Biophys. Acta 2003, 1616:184-195.
18. Allen T.M., Hamsem C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1991, 1066:29-36.
19. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., Martin F.J., Papahadjopoulos D. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1992, 1105:193-200.
20. Litzinger D.C., Huang L. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. Biochim. Biophys. Acta 1992, 1127:249-254.
21. Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1992, 1128:44-49.
22. Litzinger D.C., Buiting A.M., Rooijen N.V., Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1994, 1190:99-107.
23. Santos N.D., Allen C., Doppen A.M., Anantha M., Cox K.A., Gallagher R.C., Karlsson G., Edwards K., Kenner G., Samuels L., Webb M.S., Bally M.B. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetime to protein binding. Biochim. Biophys. Acta 2007, 1768:1367-1377.
24. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agent to solid tumors. Pharmacol. Rev. 1999, 51:691-743.
25. Gabizon A., Shmeeda H., Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin. Pharmacokinet. 2003, 42:419-436.
26. Haran G., Cohen R., Bar L.K., Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1993, 1151:201-215.
27. Grit M., Underberg W.J.M., Crommelin D.J.A. Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J. Pharm. Sci. April 1993, 82(4).
28. Sadzuka Y., Nakade A., Hirama R., Miyagishima A., Nozawa Y., Hirota S., Sonobe T. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int. J. Pharm. 2002, 238:171-180.
29. Liu D.Z., Hsieh Y.L., Chang S.Y., Chen W.Y. Microcalorimetric studies on the physical stability of poly-ethylene glycol-grafted liposome. Colloids Surf. A 2003, 212:227-234.
30. Zamboni W.C., Yoshino K. Formulation and physiological factors affecting the pharmacokinetics and pharmacodynamics of liposomal anticancer agents. Drug Deliv. Syst. 2010, 25:58-70.